Blog

Foundation, in collaboration with Dr. Martin Juneau, cardiologist and Director of Prevention at the Institute - Thursday 12 November, 2020

The statistics for type 2 diabetes are concerning: it is the world’s fifth leading cause of death due in part to the effects it can have on a person’s cardiovascular health. Dr. Martin Juneau, cardiologist and Director of Prevention at the Montreal Heart Institute, answers your questions about this disease that affects approximately 422 million adults in the world.

Foundation - Sunday 1 November, 2020

In January 2019, the Montreal Heart Institute’s EPIC Centre inaugurated the Diabetes Prevention Clinic sponsored by Sun Life. Its goal is to improve the health of type 2 diabetics and reduce their risks of developing heart disease. Learn more about this multidisciplinary diabetes prevention program.

Foundation - Monday 19 October, 2020

Humans spend about one-third of their lives asleep. Did you know that this activity can affect your cardiovascular health? In fact, many of our biological functions recover and regenerate during sleep. Here's how to improve the quality of your sleep.

Foundation - Friday 9 October, 2020

With support from the MHI Foundation’s donors, Dr. Jean-Claude Tardif was able to launch COLCOT-T2D, the second phase of the COLCOT study. The goal is to demonstrate that colchicine can also prevent cardiovascular diseases in diabetics.

Foundation - Thursday 8 October, 2020

Researchers at the Montreal Heart Institute launched a global study titled COLCOT (COLchicine Cardiovascular Outcomes Trial) in 2014. The goal was to determine whether colchicine, a widely available drug, could prevent the risk of heart attacks in patients who had already experienced this kind of event.

Foundation - Wednesday 7 October, 2020

Colchicine is an orally administered drug which has been garnering a lot of interest in the past few months. It has recently been the subject of scientific studies that have identified new indications. Let’s take a look at this readily available drug that represents a new hope for people with a variety of health conditions.

Foundation, in collaboration with Dr. Martin Juneau, cardiologist and Director of Prevention at the Institute - Monday 5 October, 2020

COVID-19 has had a significant impact on our lives these past months. Because it can be tricky to find out what is actually true among the vast amount of information available, Dr. Martin Juneau, cardiologist and Director of Prevention at the Montreal Heart Institute, answers your questions about the link between the novel coronavirus and heart disease.

Foundation, in collaboration with Dr. Serge Doucet, cardiologist and Director of Education at the Institute - Monday 21 September, 2020

Over the past few years, simulation-based education has become increasingly popular in the field of medicine. In fact, several articles have demonstrated its value and even suggested that it can reduce the number of errors made during real medical interventions. In this vein, the Institute’s Centre de formation et d’excellence en santé cardiovasculaire will soon offer new courses as part of its Simulation-based teaching program. Numerous healthcare professionals are already interested in the cardiac catheterization program.

Foundation, in collaboration with Dr. Judith Brouillette, psychiatrist - Monday 7 September, 2020

Did you know that stress has a direct effect on heart health? Though stress is vital for a healthy life, it can be harmful if it becomes chronic? Here are 5 tips to control stress and keep your heart healthy.

Foundation - Monday 24 August, 2020

The Colcorona genetic study is taking place at the Montreal Heart Institute’s Beaulieu-Saucier Pharmacogenomics Centre and is led by Dr. Marie-Pierre Dubé. This study invited participants who have already accepted to take part in the Colcorona study to voluntarily contribute their DNA. The study of their DNA will help researchers better understand why some patients develop a more severe form of COVID-19.